Catalyst Pharmaceutical CPRX Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's total cost of revenue?
- Catalyst Pharmaceutical (CPRX) reported total cost of revenue of $14.48M in Q1 2026.
- How has Catalyst Pharmaceutical's total cost of revenue changed year-over-year?
- Catalyst Pharmaceutical's total cost of revenue decreased by 19.2% year-over-year, from $17.91M to $14.48M.
- What is the long-term trend for Catalyst Pharmaceutical's total cost of revenue?
- Over 4 years (2021 to 2025), Catalyst Pharmaceutical's total cost of revenue has grown at a 41.3% compound annual growth rate (CAGR), from $21.88M to $87.25M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.